» Authors » Marie E Faughnan

Marie E Faughnan

Explore the profile of Marie E Faughnan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 99
Citations 1306
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tarulli C, Ma X, Chokar K, Vozoris N, Clancy M, Faughnan M
Orphanet J Rare Dis . 2025 Mar; 20(1):94. PMID: 40025608
Background: There has been concern that individuals living with Hereditary Hemorrhagic Telangiectasia (HHT) could be at higher risk for poor outcomes if infected with SARS-CoV2, the virus that causes COVID-19...
2.
Beslow L, Kim H, Hetts S, Ratjen F, Clancy M, Gossage J, et al.
Orphanet J Rare Dis . 2024 Nov; 19(1):421. PMID: 39522006
Background: Patients with hereditary hemorrhagic telangiectasia (HHT) are at risk for organ vascular malformations including arteriovenous malformations (AVMs) in the brain and lungs. North American HHT Centers of Excellence (CoEs)...
3.
Dinakaran S, Qutaina S, Zhao H, Tang Y, Wang Z, Ruiz S, et al.
Nat Cardiovasc Res . 2024 Nov; 3(11):1301-1317. PMID: 39487364
Increased endothelial cell proliferation is a hallmark of arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT). Here, we report a cyclin-dependent kinase 6 (CDK6)-driven mechanism of cell cycle deregulation involved...
4.
Grudzinski A, Tse B, Ombao R, Faughnan M, Pavenski K
Transfus Apher Sci . 2024 Oct; 63(6):104019. PMID: 39454475
Background: Hereditary hemorrhagic telangiectasia (HHT) is a genetic blood vessel disorder which may lead to chronic bleeding and red blood cell (RBC) transfusions. Data on transfusion requirements and complications in...
5.
DeBose-Scarlett E, Ressler A, Gallione C, Sapisochin Cantis G, Friday C, Weinsheimer S, et al.
Am J Hum Genet . 2024 Sep; 111(10):2283-2298. PMID: 39299239
Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder of vascular malformations characterized by mucocutaneous telangiectases and arteriovenous malformations (AVMs) in internal organs. HHT is caused by inheritance of a loss...
6.
Beslow L, Krings T, Kim H, Hetts S, Lawton M, Ratjen F, et al.
Pediatr Neurol . 2024 Apr; 155:120-125. PMID: 38631080
Background: Approximately 10% of people with hereditary hemorrhagic telangiectasia (HHT) have brain vascular malformations (VMs). Few reports describe de novo brain VM formation. International HHT Guidelines recommend initial brain VM...
7.
Beslow L, Vossough A, Kim H, Nelson J, Lawton M, Pollak J, et al.
Childs Nerv Syst . 2024 Mar; 40(7):2101-2108. PMID: 38517485
Objective: The brain arteriovenous malformation (BAVM) nidus compactness score (CS), determined on angiography, predicts BAVM recurrence after surgical resection among children with sporadic BAVMs. We measured the angiographic CS for...
8.
Kilian A, Latino G, White A, Ratjen F, McDonald J, Whitehead K, et al.
J Clin Med . 2023 Dec; 12(23). PMID: 38068512
We are grateful to Eker et al. for their thoughtful analysis and response to our publication titled Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with...
9.
Cheng H, Faughnan M, terBrugge K, Liu H, Krings T
AJNR Am J Neuroradiol . 2023 Dec; 44(12):1367-1372. PMID: 38050014
Background And Purpose: The association between hereditary hemorrhagic telangiectasia and intracranial aneurysms remains controversial. This study evaluated the prevalence and characteristics of intracranial aneurysms in patients with hereditary hemorrhagic telangiectasia...
10.
Botsford A, Tradi F, Loubet A, Tantawi S, Soulez G, Giroux M, et al.
J Vasc Interv Radiol . 2023 Nov; 35(3):349-360. PMID: 38013007
Purpose: To compare the safety, effectiveness, and persistence rates of 0.018-inch coils with those of Amplatzer vascular plugs (AVPs; Abbott Vascular, Abbott Park, Illinois) for the treatment of pulmonary arteriovenous...